Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, October 22, 2026

Back to today

From X

@convequity

Convequity on X

We own both $ONTO and $CAMT because they sell overlapping tools to different HBM makers, and we raised Onto while holding Camtek. In our 4Q26 portfolio rebalance we increased Onto in our portfolio and held Camtek unchanged. Inspection identifies defects. Metrology measures dimensions and material properties to check that manufacturing meets specifications. Both companies sell inspection and metrology tools for HBM and advanced packaging, but their customer exposure differs. Onto is more closely tied to SK hynix's capital-spending plans. Our industry information identifies Camtek as a preferred supplier for Samsung's HBM production lines, and Samsung is investing aggressively to catch up with SK hynix in HBM. Camtek is smaller and more specialized, and we see a technical edge in selected HBM applications. Onto also sells chip-fabrication metrology and packaging lithography, which Camtek does not offer. We raised Onto because increasingly complex chip designs give customers reasons to keep investing beyond the current packaging recovery. We hold Camtek as the more focused advanced-packaging investment.

Investor Letters

All letters

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4B
Monte Independent Investment Research 5 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 24 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.5B
Latticework by MOI Global 4 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $108M
Triple S Special Situations Investing 4 clicks

Tesla Q3 FY12/26 Earnings Analysis

Tesla’s Q3 revenue was flat at $28.0 billion, while operating income fell 56% as R&D spending on AI rose 69%; SpaceX merger discussions are…

TSLA $1.5T
Cestrian Capital Research 6 clicks

Meta Earnings Update: Q3 2026

Meta’s Q3 revenue rose 26% to $64.6 billion, but $34.9 billion in AI infrastructure spending drove free cash flow negative as it created…

META $1.8T
SixSigmaCapital: Navigating the Financial Markets 3 clicks

Meta: 3Q26 Business Update

Meta’s Family of Apps revenue grew 26% as Muse reached 10 million users, testing AI-agent commerce while Amazon restricts access and…

META $1.8T
Speedwell Memos 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 55 of 247

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.